For research use only. We do not sell to patients.
trans-Pralsetinib
CAS No. : 2097132-93-7
Biological Activity：trans-Pralsetinib (trans-BLU-667) is a rearranged during transfection (RET) inhibitor extracted from patent US20170121312A1, Compound Example 129.
Research Area：Cancer
Targets：RET
Related Screening Libraries:Bioactive Compound Library Plus;Kinase Inhibitor Library;Protein Tyrosine Kinase Compound Library;Anti-Cancer Compound Library;Anti-Lung Cancer Compound Library;Targeted Diversity Library;Anti-Liver Cancer Compound Library ;Human Metabolite Library;
Related Small Molecules:RET-IN-18;Zeteletinib;RET-IN-5;GSK3179106;Pyrazoloadenine;PF 477736;BT-13;RET-IN-8;AD80;JNJ-38158471;Amuvatinib hydrochloride;RET-IN-11;TRK II-IN-1;RET-IN-10;RET-IN-17;RET-IN-7;RET-IN-13;TG101209;WHI-P180;TAS05567;RET-IN-14;FLT3/ITD-IN-4;Pz-1
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
